BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 2121664)

  • 21. DDAVP infusion in haemophilia A carriers: different behaviour of plasma factor VIII and von Willebrand factor.
    Casonato A; Dannhauser D; Pontara E; Bertomoro A; Orazi B; Santarossa L; Zerbinati P; Girolami A
    Blood Coagul Fibrinolysis; 1996 Jul; 7(5):549-53. PubMed ID: 8874865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A bleeding disease (von Willebrand's disease) in a Chesapeake Bay Retriever.
    Johnson GS; Lees GE; Benson RE; Rosborough TK; Dodds WJ
    J Am Vet Med Assoc; 1980 Jun; 176(11):1261-3. PubMed ID: 6776082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fainting induces an acute increase in the concentration of plasma factor VIII and von Willebrand factor.
    Casonato A; Pontara E; Bertomoro A; Cattini MG; Soldera C; Girolami A
    Haematologica; 2003 Jun; 88(6):688-93. PubMed ID: 12801845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Von Willebrand's disease complicating second-trimester abortion.
    Sorosky J; Klatsky A; Nobert GF; Burchell RC
    Obstet Gynecol; 1980 Feb; 55(2):253-4. PubMed ID: 6965426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined haemophilia A and type I von Willebrand's disease: a family study including an evaluation of the effects of DDAVP infusion.
    Casonato A; Pontara E; Boscaro M; Dannhauser D; Sartori MT; Girolami A
    Haematologia (Budap); 1993; 25(1):57-67. PubMed ID: 8339998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acquired haemophilia in association with type III von Willebrand's disease: successful treatment with high purity von Willebrand's factor and recombinant factor VIIa.
    Majumdar G; Phillips JK; Lavallee H; Savidge GF
    Blood Coagul Fibrinolysis; 1993 Dec; 4(6):1035-7. PubMed ID: 8148477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 1-Desamino-8-arginine-vasopressin corrects the hemostatic defects in type 2B von Willebrand's disease.
    McKeown LP; Connaghan G; Wilson O; Hansmann K; Merryman P; Gralnick HR
    Am J Hematol; 1996 Feb; 51(2):158-63. PubMed ID: 8579058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of von Willebrand's disease.
    Mannucci PM
    J Intern Med Suppl; 1997; 740():129-32. PubMed ID: 9350194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. No influence of blood group on the responsiveness to desmopressin in type I "platelet normal" von Willebrand's disease.
    Castaman G; Rodeghiero F
    Thromb Haemost; 1995 Mar; 73(3):551-2. PubMed ID: 7667843
    [No Abstract]   [Full Text] [Related]  

  • 30. Development and present status of concentrate therapy for hemophilia and von Willebrand's disease.
    Brinkhous KM
    Wien Klin Wochenschr; 1982 Oct; 94(19):509-14. PubMed ID: 6818773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of D-arginine vasopressin in von Willebrand's disease.
    Bala L; Boggio L; Green D
    Curr Hematol Rep; 2005 Jan; 4(1):1-2. PubMed ID: 15610653
    [No Abstract]   [Full Text] [Related]  

  • 32. [Hemostatic effect of deamino-8-D-arginine vasopressin (DDAVP) in hemophilia A and von Willebrand's disease].
    Fukui H; Takase T
    Rinsho Ketsueki; 1985 Jul; 26(7):1069-79. PubMed ID: 3932720
    [No Abstract]   [Full Text] [Related]  

  • 33. Correlation between circulating levels of von Willebrand's antigen II and von Willebrand factor: discrimination between type I and type II von Willebrand's disease.
    McCarroll DR; Ruggeri ZM; Montgomery RR
    J Lab Clin Med; 1984 May; 103(5):704-11. PubMed ID: 6609219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Open-heart surgery in von Willebrand's disease.
    Aris A; Pisciotta AV; Hussey CV; Gale H; Lepley D
    J Thorac Cardiovasc Surg; 1975 Feb; 69(2):183-7. PubMed ID: 1078707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical effectiveness of desmopressin in a case of acquired von Willebrand's syndrome associated with benign monoclonal gammopathy.
    Castaman G; Rodeghiero F; Di Bona E; Ruggeri M
    Blut; 1989 Apr; 58(4):211-3. PubMed ID: 2784985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Sugar-chain of factor VIII/von Willebrand factor in von Willebrand's disease. Analysis by immuno-affinoelectrophoresis using lectin].
    Ueda M; Yasui M; Nishino M; Mikami S; Fukui H
    Nihon Ketsueki Gakkai Zasshi; 1983 Sep; 46(5):1117-23. PubMed ID: 6421045
    [No Abstract]   [Full Text] [Related]  

  • 37. [Von Willebrand's disease (author's transl)].
    Fukui H
    Rinsho Ketsueki; 1977 May; 18(5):575-86. PubMed ID: 333144
    [No Abstract]   [Full Text] [Related]  

  • 38. Acquired type II von Willebrand's disease: demonstration of a complexed inhibitor of the von Willebrand factor-platelet interaction and response to treatment.
    Goudemand J; Samor B; Caron C; Jude B; Gosset D; Mazurier C
    Br J Haematol; 1988 Feb; 68(2):227-33. PubMed ID: 3126793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of desmopressin in the management of two patients with von Willebrand's disease undergoing periodontal surgery. 2 case reports.
    Petrover MG; Cohen CI
    J Periodontol; 1990 Apr; 61(4):239-42. PubMed ID: 2324924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acquired von Willebrand's disease, platelet-release defect and angiodysplasia.
    Rosborough TK; Swaim WR
    Am J Med; 1978 Jul; 65(1):96-100. PubMed ID: 308316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.